BRYAN HAYES: Open Payments
NPI 1679958946 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $94 |
| Gilead Sciences, Inc. | 1 | $34 |
| GENZYME CORPORATION | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
Products named: INTERSTIM, DUPIXENT, Livdelzi, ENTYVIO, Wegovy.
Industry payments across ME — which companies pay providers there.
